Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-2446
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)